Your browser doesn't support javascript.
loading
Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency.
Chen, Chen; Wakabayashi, Tetsuya; Muraoka, Masaru; Shu, Feng; Wei Shan, Chia; Chor Kun, Chong; Tim Jang, Ching; Soehano, Ishin; Shimizu, Yuichiro; Igawa, Tomoyuki; Nezu, Jun-Ichi.
Afiliação
  • Chen C; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Wakabayashi T; b Discovery Biologics Department, Research Division , Chugai Pharmaceutical Co., Ltd ., Gotemba , Shizuoka , Japan.
  • Muraoka M; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Shu F; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Wei Shan C; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Chor Kun C; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Tim Jang C; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Soehano I; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Shimizu Y; a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
  • Igawa T; b Discovery Biologics Department, Research Division , Chugai Pharmaceutical Co., Ltd ., Gotemba , Shizuoka , Japan.
  • Nezu JI; b Discovery Biologics Department, Research Division , Chugai Pharmaceutical Co., Ltd ., Gotemba , Shizuoka , Japan.
MAbs ; 11(4): 632-638, 2019.
Article em En | MEDLINE | ID: mdl-30898021
The complex molecular formats of recent therapeutic antibodies, including bispecific antibodies, antibody fragments, and other fusion proteins, makes the task of purifying the desired molecules in a limited number of purification steps more and more challenging. Manufacturing these complicated biologics can be substantially improved in the affinity capture stage if the simple bind-and-elute mode is accompanied by targeted removal of the impurities, such as mis-paired antibodies and oligomers or aggregates. Here, we report a method, based on the binding valency to Protein L resin, of separating proteins during the elution step by simply controlling the conductivity at low pH. We show that the method efficiently separated targeted antibodies from mis-paired and aggregated species. Notably, the number of Protein L binding sites can be built into the molecule by design to facilitate the purification. This method may be useful for purifying various antibody formats at laboratory and manufacturing scales.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Cromatografia de Afinidade / Anticorpos Biespecíficos / Anticorpos de Cadeia Única / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Cromatografia de Afinidade / Anticorpos Biespecíficos / Anticorpos de Cadeia Única / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article